TY - JOUR
AU - Singh, Sally J
AU - Baldwin, Molly
AU - Daynes, Enya
AU - Evans, Rachael A.
AU - Greening, Neil J.
AU - Jenkins, R. Gisli
AU - Lone, Nazir I.
AU - McAuley, Hamish
AU - Mehta, Puja R.
AU - Newman, Joseph
AU - Novotny, Petr
AU - Smith, David J F
AU - Stanel, Stefan C
AU - Toshner, Mark
AU - Brightling, Christopher E.
PY - 2023
DA - May
TI - Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation
JO - The Lancet Respiratory Medicine
DO - https://doi.org/10.1016/S2213-2600(23)00159-5
AB - Although the exact prevalence of post-COVID-19 condition (also known as long COVID) is unknown, more than a third of patients with COVID-19 develop symptoms that persist for more than 3 months after SARS-CoV-2 infection. These sequelae are highly heterogeneous in nature and adversely affect multiple biological systems, although breathlessness is a frequently cited symptom. Specific pulmonary sequelae, including pulmonary fibrosis and thromboembolic disease, need careful assessment and might require particular investigations and treatments. COVID-19 outcomes in people with pre-existing respiratory conditions vary according to the nature and severity of the respiratory disease and how well it is controlled. Extrapulmonary complications such as reduced exercise tolerance and frailty might contribute to breathlessness in post-COVID-19 condition. Non-pharmacological therapeutic options, including adapted pulmonary rehabilitation programmes and physiotherapy techniques for breathing management, might help to attenuate breathlessness in people with post-COVID-19 condition. Further research is needed to understand the origins and course of respiratory symptoms and to develop effective therapeutic and rehabilitative strategies.
PB - Elsevier
UR - https://www.research.ed.ac.uk/en/publications/74857eee-2fa5-49a1-87c2-178b92f68fbb
KW - Coronavirus (COVID-19)
ER